Literature DB >> 20564555

Accumulation of D-beta-aspartic acid-containing proteins in age-related ocular diseases.

Yuichi Kaji1, Tetsuro Oshika, Yutaka Takazawa, Masashi Fukayama, Noriko Fujii.   

Abstract

Transparency is essential for eyes, which serve as cameras. However, decreased transparency caused by accumulation of abnormal proteins is commonly observed especially in elderly people. However, the mechanism of accumulation of abnormal proteins in various ocular diseases is still unclear. In the present study, we investigated the role of D-amino acids in the development of accumulation of abnormal proteins in age-related ocular diseases. Whole eyes with age-related macular degeneration were excised from four patients. Surgical specimens with pinguecula were excised from eight patients, and specimens with climatic droplet keratopathy were excised from three patients. Polyclonal antibody to the D-beta-Asp-containing peptide was prepared. Using the antibody, immunohistochemical localization of D-beta-Asp-containing proteins was determined. In eyes with age-related macular degeneration, accumulation of abnormal proteins was observed between the retinal pigment epithelial cells and Bruch's membrane. The accumulated abnormal proteins were positive for D-beta-Asp-containing peptides. In surgical specimens with pinguecula and climatic droplet keratopathy, abnormal accumulation of proteins seen in the superficial layer of the stroma was positive for D-beta-Asp-containing peptide. The results indicate that development of D-beta-Asp-containing proteins in vivo have a central role in the development of accumulation of abnormal proteins in age-related macular degeneration, pinguecula, and climatic drop-like dystrophy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564555     DOI: 10.1002/cbdv.200900329

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  7 in total

1.  The microRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: implications for apoptosis regulation.

Authors:  Irene Sambri; Rosanna Capasso; Piero Pucci; Alessandra F Perna; Diego Ingrosso
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

2.  Phospholipidomic Studies in Human Cornea From Climatic Droplet Keratopathy.

Authors:  Maria Fernanda Suarez; Maria Carmen Piqueras; Leandro Correa; Evangelina Esposito; Maria Fernanda Barros; Sanjoy K Bhattacharya; Julio A Urrets-Zavalia; Horacio M Serra
Journal:  J Cell Biochem       Date:  2017-05-23       Impact factor: 4.429

3.  Predicting Reaction Mechanisms for the Threonine-Residue Stereoinversion Catalyzed by a Dihydrogen Phosphate Ion.

Authors:  Tomoki Nakayoshi; Koichi Kato; Eiji Kurimoto; Yu Takano; Akifumi Oda
Journal:  ACS Omega       Date:  2022-05-26

4.  Benzalkonium chloride accelerates the formation of the amyloid fibrils of corneal dystrophy-associated peptides.

Authors:  Yusuke Kato; Hisashi Yagi; Yuichi Kaji; Tetsuro Oshika; Yuji Goto
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

5.  Co-localisation of advanced glycation end products and D-β-aspartic acid-containing proteins in gelatinous drop-like corneal dystrophy.

Authors:  Yuichi Kaji; Tetsuro Oshika; Yutaka Takazawa; Masashi Fukayama; Noriko Fujii
Journal:  Br J Ophthalmol       Date:  2012-06-13       Impact factor: 4.638

6.  Climatic Droplet Keratopathy in Argentina: Involvement of Environmental Agents in Its Genesis Which Would Open the Prospect for New Therapeutic Interventions.

Authors:  María Fernanda Suárez; Leandro Correa; Nicolás Crim; Evangelina Espósito; Rodolfo Monti; Julio Alberto Urrets-Zavalía; Horacio Marcelo Serra
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

7.  Mechanisms of Deamidation of Asparagine Residues and Effects of Main-Chain Conformation on Activation Energy.

Authors:  Koichi Kato; Tomoki Nakayoshi; Eiji Kurimoto; Akifumi Oda
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.